High incidence of silent cerebral infarcts in adult patients with beta thalassemia major

Thromb Res. 2016 Aug:144:119-22. doi: 10.1016/j.thromres.2016.06.010. Epub 2016 Jun 14.

Abstract

Objectives: Survival of beta thalassemia major (TM) patients has improved significantly over the past few decades. Consequently, less commonly reported complications are now being recognized. An incidence as high as 60% of silent cerebral infarcts (SCI) has been demonstrated by brain Magnetic Resonance Imaging (MRI) studies in beta thalassemia intermedia (TI). The aim of this study was to determine whether regularly transfused TM adult patients experience less SCI, as compared to the incidence described in TI.

Methods: In this observational study, 28 transfusion dependent TM patients, >18years of age underwent brain MRI studies.

Results: Focal bright foci in the cerebral white matter were demonstrated in 17 (60.7%) patients; most of them had multiple lesions. Elevated serum ferritin (SF), primarily 5years Area Under the Curve, was found to have a significant association with the presence of SCI (p<0.031). Similar results were found when 4 patients with intact spleen and 2 patients with splenules were excluded (p=0.027). There was no significant association between number of SCI and clinical or other laboratory parameter evaluated.

Conclusions: The present study demonstrates a high rate of SCI in regularly transfused TM adult patients. Effective continuous iron chelation, preventive low dose aspirin and routine periodical brain MRI are recommended.

Keywords: Adult patients; Beta thalassemia major; Iron chelation; Silent cerebral infarcts; Transfusion dependent.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Aspirin / therapeutic use
  • Cerebral Infarction / blood
  • Cerebral Infarction / diagnostic imaging*
  • Cerebral Infarction / drug therapy
  • Cerebral Infarction / etiology*
  • Cerebrum / diagnostic imaging*
  • Cerebrum / drug effects
  • Cerebrum / pathology
  • Female
  • Ferritins / blood
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Incidence
  • Iron Chelating Agents / therapeutic use
  • Magnetic Resonance Imaging
  • Male
  • Transfusion Reaction
  • Young Adult
  • beta-Thalassemia / blood
  • beta-Thalassemia / complications*
  • beta-Thalassemia / therapy

Substances

  • Fibrinolytic Agents
  • Iron Chelating Agents
  • Ferritins
  • Aspirin